As mentioned above, this article focuses exclusively on exploiting the JUN-fibrosarcoma progression series for the identification of potential invasiveness markers and therapeutic targets, and we have good indications that the complementary part of our transcriptomic analysis resulting in the identification of proliferation-related genes (Table 2) bears a great potential for improving our understanding of complex sarcoma biology as well. Here, JUN is linked to sarcoma.